“…Relaxation of the triplet excited state by radioactive decay would usually result in phosphorescence with large Stokes shifts. [1a] Since the first reports [4,5] on the photoluminescence of [Au 2 (μ-dppm) 2 ] 2+ , di and polynuclear gold(I) phosphane derivatives have been widely studied, [1,6] including organometallic compounds, [7] compounds with sulfur- [6g,n,8] and nitrogen-containing [9] ligands and chalcogenide centred gold derivatives. [10] In some cases the short gold(I)…gold(I) distances in these derivatives may not play a decisive role in determining the emission energy, as the auxiliary counter anion or solvent can dramatically affect their photophysical properties.…”
The reaction of new dinuclear gold(I) organometallic complexes containing mesityl ligands and bridging bidentate phosphanes [Au2(mes)2(μ-LL)] (LL = dppe: 1,2-Bis(di-phenylphosphano)ethane 1a, and water-soluble dppy: 1,2-Bis(di-3-pyridylphosphano)ethane 1b) with Ag+ and Cu+ lead to the formation of a family of heterometallic clusters with mesityl bridging ligands of the general formula [Au2M(μ-mes)2(μ-LL)]A (M = Ag, A = ClO4−, L-L = dppe 2a, dppy 2b; M = Ag, A = SO3CF3−, L-L = dppe 3a, dppy 3b; M = Cu, A = PF6−, L-L = dppe 4a, dppy 4b). The new compounds were characterized by different spectroscopic techniques and mass spectrometry The crystal structures of [Au2(mes)2(μ-dppy)] 1b and [Au2Ag(μ-mes)2(μ-dppe)]SO3CF3
3a were determined by a single-crystal X-ray diffraction study. 3a in solid state is not a cyclic trinuclear Au2Ag derivative but it gives an open polymeric structure instead, with the {Au2(μ-dppe)} fragments “linked” by Ag(μ-mes)2 units. The very short distances of 2.7559(6) Å (Au-Ag) and 2.9229(8) Å (Au-Au) are indicative of gold-silver (metallophillic) and aurophilic interactions. A systematic study of their luminescence properties revealed that all compounds are brightly luminescent in solid state, at room temperature (RT) and at 77 K, or in frozen DMSO solutions with lifetimes in the microsecond range and probably due to the self-aggregation of [Au2M(μ-mes)2(μ-LL)]+ units (M= Ag or Cu; LL= dppe or dppy) into an extended chain structure, through Au-Au and/or Au-M metallophylic interactions, as that observed for 3a. In solid state the heterometallic Au2M complexes with dppe (2a–4a) show a shift of emission maxima (from ca. 430 to the range of 520–540 nm) as compared to the parent dinuclear organometallic product 1a while the complexes with dppy (2b–4b) display a more moderate shift (505 for 1b to a max of 563 nm for 4b).
More importantly, compound [Au2Ag(μ-mes)2(μ-dppy)]ClO4
2b resulted luminescent in diluted DMSO solution at room temperature. Previously reported compound [Au2Cl2(μ-LL)] (L-L dppy 5b) was also studied for comparative purposes. The antimicrobial activity of 1–5 and AgA (A= ClO4−, OSO2CF3−) against Gram-positive and Gram-negative bacteria and yeast was evaluated. Most tested compounds displayed moderate to high antibacterial activity while heteronuclear Au2M derivatives with dppe (2a–4a) were the more active (MIC 10 to 1 μg/mL). Compounds containing silver were ten times more active to Gram-negative bacteria than the parent dinuclear compound 1a or silver salts. Au2Ag compounds with dppy (2b, 3b) were also potent against fungi.
“…Relaxation of the triplet excited state by radioactive decay would usually result in phosphorescence with large Stokes shifts. [1a] Since the first reports [4,5] on the photoluminescence of [Au 2 (μ-dppm) 2 ] 2+ , di and polynuclear gold(I) phosphane derivatives have been widely studied, [1,6] including organometallic compounds, [7] compounds with sulfur- [6g,n,8] and nitrogen-containing [9] ligands and chalcogenide centred gold derivatives. [10] In some cases the short gold(I)…gold(I) distances in these derivatives may not play a decisive role in determining the emission energy, as the auxiliary counter anion or solvent can dramatically affect their photophysical properties.…”
The reaction of new dinuclear gold(I) organometallic complexes containing mesityl ligands and bridging bidentate phosphanes [Au2(mes)2(μ-LL)] (LL = dppe: 1,2-Bis(di-phenylphosphano)ethane 1a, and water-soluble dppy: 1,2-Bis(di-3-pyridylphosphano)ethane 1b) with Ag+ and Cu+ lead to the formation of a family of heterometallic clusters with mesityl bridging ligands of the general formula [Au2M(μ-mes)2(μ-LL)]A (M = Ag, A = ClO4−, L-L = dppe 2a, dppy 2b; M = Ag, A = SO3CF3−, L-L = dppe 3a, dppy 3b; M = Cu, A = PF6−, L-L = dppe 4a, dppy 4b). The new compounds were characterized by different spectroscopic techniques and mass spectrometry The crystal structures of [Au2(mes)2(μ-dppy)] 1b and [Au2Ag(μ-mes)2(μ-dppe)]SO3CF3
3a were determined by a single-crystal X-ray diffraction study. 3a in solid state is not a cyclic trinuclear Au2Ag derivative but it gives an open polymeric structure instead, with the {Au2(μ-dppe)} fragments “linked” by Ag(μ-mes)2 units. The very short distances of 2.7559(6) Å (Au-Ag) and 2.9229(8) Å (Au-Au) are indicative of gold-silver (metallophillic) and aurophilic interactions. A systematic study of their luminescence properties revealed that all compounds are brightly luminescent in solid state, at room temperature (RT) and at 77 K, or in frozen DMSO solutions with lifetimes in the microsecond range and probably due to the self-aggregation of [Au2M(μ-mes)2(μ-LL)]+ units (M= Ag or Cu; LL= dppe or dppy) into an extended chain structure, through Au-Au and/or Au-M metallophylic interactions, as that observed for 3a. In solid state the heterometallic Au2M complexes with dppe (2a–4a) show a shift of emission maxima (from ca. 430 to the range of 520–540 nm) as compared to the parent dinuclear organometallic product 1a while the complexes with dppy (2b–4b) display a more moderate shift (505 for 1b to a max of 563 nm for 4b).
More importantly, compound [Au2Ag(μ-mes)2(μ-dppy)]ClO4
2b resulted luminescent in diluted DMSO solution at room temperature. Previously reported compound [Au2Cl2(μ-LL)] (L-L dppy 5b) was also studied for comparative purposes. The antimicrobial activity of 1–5 and AgA (A= ClO4−, OSO2CF3−) against Gram-positive and Gram-negative bacteria and yeast was evaluated. Most tested compounds displayed moderate to high antibacterial activity while heteronuclear Au2M derivatives with dppe (2a–4a) were the more active (MIC 10 to 1 μg/mL). Compounds containing silver were ten times more active to Gram-negative bacteria than the parent dinuclear compound 1a or silver salts. Au2Ag compounds with dppy (2b, 3b) were also potent against fungi.
“…[29,30] For Au I complexes containing both phosphane and thiolate ligands, the lower-energy emissions in the solid state have been experimentally attributed to AuǞthiolate charge transfer (MLCT). [11,17,24,31Ϫ36] Bruce's studies on a series of dinuclear (phosphane)Au I thiolates with or without AuϪAu interaction showed that the interaction is not a necessary condition for luminescence and that its presence does not significantly perturb the luminescence; [32] however, Fackler and co-workers found that the emission maximum in the luminescence of many mononuclear (phosphane)Au I thiolate complexes can be affected by an AuϪAu interaction. [11] In fact, such studies are not incompatible.…”
“…The mechanisms of emission from mononuclear species are complex, but many involve substantial Ligand to Metal Charge Transfer (LMCT) character [50]. However, dinuclear complexes which have goldegold distances small enough to allow aurophilic interactions can luminesce via a Ligand to MetaleMetal Charge Transfer (LMMCT) mechanism which can lead to a significantly red-shifted excitation and emission profile by comparison with the analogous mononuclear species [51].…”
Section: -Organometallic Gold Complexes In Cell Imagingmentioning
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.